BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Max with another great prediction. It appears peptides may indeed be the biggest consumer category of 2026. Great for $HIMS, Superpower, and many others. What will be the most popular peptides? Who Is BPC 157 Banned? Oral vs. Injectable Forms Explained The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York